Zentalis Pharmaceuticals, Inc. (ZNTL) › Shareholders' EquityZentalis Pharmaceuticals, Inc. (ZNTL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $32.31M2019: -$73.28M2020: $333.38M2021: $364.48M2022: $434.02M2023: $437.39M2024: $337.19M2025: $216.20M$216.20M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$216.20M-35.9%2024$337.19M-22.9%2023$437.39M+0.8%2022$434.02M+19.1%2021$364.48M+9.3%2020$333.38M+554.9%2019-$73.28M-326.8%2018$32.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share